LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 23

Search options

  1. Article ; Online: The FAM13A Long Isoform Regulates Cilia Movement and Co-ordination in Airway Mucociliary Transport.

    Howes, Ashleigh / Rogerson, Clare / Belyaev, Nikolai / Karagyozova, Tina / Rapiteanu, Radu / Fradique, Ricardo / Pellicciotta, Nicola / Mayhew, David / Hurd, Catherine / Crotta, Stefania / Singh, Tanya / Dingwell, Kevin / Myatt, Anniek / Arad, Navot / Hasan, Hikmatyar / Bijlsma, Hielke / Panjwani, Aliza / Vijayan, Vinaya / Young, George /
    Bridges, Angela / Petit-Frere, Sebastien / Betts, Joanna / Larminie, Chris / Smith, James C / Hessel, Edith M / Michalovich, David / Walport, Louise / Cicuta, Pietro / Powell, Andrew J / Beinke, Soren / Wack, Andreas

    American journal of respiratory cell and molecular biology

    2024  

    Abstract: ... SNPs in ... ...

    Abstract SNPs in the
    Language English
    Publishing date 2024-05-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1025960-0
    ISSN 1535-4989 ; 1044-1549
    ISSN (online) 1535-4989
    ISSN 1044-1549
    DOI 10.1165/rcmb.2024-0063OC
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection.

    Aegerter, Helena / Kulikauskaite, Justina / Crotta, Stefania / Patel, Harshil / Kelly, Gavin / Hessel, Edith M / Mack, Matthias / Beinke, Soren / Wack, Andreas

    Nature immunology

    2020  Volume 21, Issue 2, Page(s) 145–157

    Abstract: Despite the prevalence and clinical importance of influenza, its long-term effect on lung immunity is unclear. Here we describe that following viral clearance and clinical recovery, at 1 month after infection with influenza, mice are better protected ... ...

    Abstract Despite the prevalence and clinical importance of influenza, its long-term effect on lung immunity is unclear. Here we describe that following viral clearance and clinical recovery, at 1 month after infection with influenza, mice are better protected from Streptococcus pneumoniae infection due to a population of monocyte-derived alveolar macrophages (AMs) that produce increased interleukin-6. Influenza-induced monocyte-derived AMs have a surface phenotype similar to resident AMs but display a unique functional, transcriptional and epigenetic profile that is distinct from resident AMs. In contrast, influenza-experienced resident AMs remain largely similar to naive AMs. Thus, influenza changes the composition of the AM population to provide prolonged antibacterial protection. Monocyte-derived AMs persist over time but lose their protective profile. Our results help to understand how transient respiratory infections, a common occurrence in human life, can constantly alter lung immunity by contributing monocyte-derived, recruited cells to the AM population.
    MeSH term(s) Animals ; Immunity, Innate/immunology ; Macrophages, Alveolar/immunology ; Mice ; Orthomyxoviridae Infections/immunology ; Pneumococcal Infections/immunology
    Language English
    Publishing date 2020-01-13
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-019-0568-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Rhinovirus-induced Human Lung Tissue Responses Mimic Chronic Obstructive Pulmonary Disease and Asthma Gene Signatures.

    Wronski, Sabine / Beinke, Soren / Obernolte, Helena / Belyaev, Nikolai N / Saunders, Ken A / Lennon, Mark G / Schaudien, Dirk / Braubach, Peter / Jonigk, Danny / Warnecke, Gregor / Zardo, Patrick / Fieguth, Hans-Gerd / Wilkens, Ludwig / Braun, Armin / Hessel, Edith M / Sewald, Katherina

    American journal of respiratory cell and molecular biology

    2021  Volume 65, Issue 5, Page(s) 544–554

    Abstract: Human rhinovirus (RV) is a major risk factor for chronic obstructive pulmonary disease (COPD) and asthma exacerbations. The exploration of RV pathogenesis has been hampered by a lack of disease-relevant model systems. We performed a detailed ... ...

    Abstract Human rhinovirus (RV) is a major risk factor for chronic obstructive pulmonary disease (COPD) and asthma exacerbations. The exploration of RV pathogenesis has been hampered by a lack of disease-relevant model systems. We performed a detailed characterization of host responses to RV infection in human lung tissue
    MeSH term(s) Aged ; Antiviral Agents/pharmacology ; Asthma/genetics ; Asthma/pathology ; Bronchi/pathology ; Bronchi/physiology ; Epithelial Cells/pathology ; Epithelial Cells/virology ; Female ; Gene Expression Profiling ; Genome, Human ; Host-Pathogen Interactions/genetics ; Humans ; Isoxazoles/pharmacology ; Lung/physiology ; Lung/virology ; Male ; Middle Aged ; Phenylalanine/analogs & derivatives ; Phenylalanine/pharmacology ; Picornaviridae Infections/drug therapy ; Picornaviridae Infections/genetics ; Picornaviridae Infections/pathology ; Pulmonary Disease, Chronic Obstructive/genetics ; Pulmonary Disease, Chronic Obstructive/pathology ; Pyrrolidinones/pharmacology ; Rhinovirus/pathogenicity ; Valine/analogs & derivatives ; Valine/pharmacology
    Chemical Substances Antiviral Agents ; Isoxazoles ; Pyrrolidinones ; Phenylalanine (47E5O17Y3R) ; Valine (HG18B9YRS7) ; rupintrivir (RGE5K1Q5QW)
    Language English
    Publishing date 2021-07-31
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1025960-0
    ISSN 1535-4989 ; 1044-1549
    ISSN (online) 1535-4989
    ISSN 1044-1549
    DOI 10.1165/rcmb.2020-0337OC
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Corrected Super-Resolution Microscopy Enables Nanoscale Imaging of Autofluorescent Lung Macrophages.

    Ambrose, Ashley R / Dechantsreiter, Susanne / Shah, Rajesh / Montero, M Angeles / Quinn, Anne Marie / Hessel, Edith M / Beinke, Soren / Tannahill, Gillian M / Davis, Daniel M

    Biophysical journal

    2020  Volume 119, Issue 12, Page(s) 2403–2417

    Abstract: Observing the cell surface and underlying cytoskeleton at nanoscale resolution using super-resolution microscopy has enabled many insights into cell signaling and function. However, the nanoscale dynamics of tissue-specific immune cells have been ... ...

    Abstract Observing the cell surface and underlying cytoskeleton at nanoscale resolution using super-resolution microscopy has enabled many insights into cell signaling and function. However, the nanoscale dynamics of tissue-specific immune cells have been relatively little studied. Tissue macrophages, for example, are highly autofluorescent, severely limiting the utility of light microscopy. Here, we report a correction technique to remove autofluorescent noise from stochastic optical reconstruction microscopy (STORM) data sets. Simulations and analysis of experimental data identified a moving median filter as an accurate and robust correction technique, which is widely applicable across challenging biological samples. Here, we used this method to visualize lung macrophages activated through Fc receptors by antibody-coated glass slides. Accurate, nanoscale quantification of macrophage morphology revealed that activation induced the formation of cellular protrusions tipped with MHC class I protein. These data are consistent with a role for lung macrophage protrusions in antigen presentation. Moreover, the tetraspanin protein CD81, known to mark extracellular vesicles, appeared in ring-shaped structures (mean diameter 93 ± 50 nm) at the surface of activated lung macrophages. Thus, a moving median filter correction technique allowed us to quantitatively analyze extracellular secretions and membrane structure in tissue-derived immune cells.
    MeSH term(s) Cell Membrane ; Lung ; Macrophages ; Microscopy ; Microtubules
    Language English
    Publishing date 2020-11-18
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218078-9
    ISSN 1542-0086 ; 0006-3495
    ISSN (online) 1542-0086
    ISSN 0006-3495
    DOI 10.1016/j.bpj.2020.10.041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Highly efficient genome editing in primary human bronchial epithelial cells differentiated at air-liquid interface.

    Rapiteanu, Radu / Karagyozova, Tina / Zimmermann, Natalie / Singh, Kuljit / Wayne, Gareth / Martufi, Matteo / Belyaev, Nikolai N / Hessel, Edith M / Michalovich, David / Macarron, Ricardo / Rowan, Wendy C / Cairns, William J / Roger, Jan / Betts, Joanna / Beinke, Soren / Maratou, Klio

    The European respiratory journal

    2020  Volume 55, Issue 5

    MeSH term(s) Bronchi/cytology ; Cell Culture Techniques/methods ; Cell Differentiation/genetics ; Epithelial Cells/metabolism ; Gene Editing/methods ; Humans ; Respiratory Mucosa/metabolism
    Language English
    Publishing date 2020-05-21
    Publishing country England
    Document type Letter
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.00950-2019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection.

    Groeger, David / Schiavi, Elisa / Grant, Ray / Kurnik-Łucka, Magdalena / Michalovich, David / Williamson, Rick / Beinke, Soren / Kiely, Barry / Akdis, Cezmi A / Hessel, Edith M / Shanahan, Fergus / O' Mahony, Liam

    EBioMedicine

    2020  Volume 60, Page(s) 102981

    Abstract: Background: Prophylactic strategies are urgently needed for prevention of severe inflammatory responses to respiratory viral infections. Bacterial-host interactions may modify the immune response to viral infections.: Methods: We examined the ... ...

    Abstract Background: Prophylactic strategies are urgently needed for prevention of severe inflammatory responses to respiratory viral infections. Bacterial-host interactions may modify the immune response to viral infections.
    Methods: We examined the contribution of Intranasal administration of two different Bifidobacterium longum strains or its isolated cell wall in controlling viral induced inflammation using a murine model of influenza infection. We monitored mortality and morbidity over a 10-day period and viral load, differential broncho alveolar lavage (BAL) fluid inflammatory cell counts, Lung tissue histology, BAL and serum cytokines, markers of vascular damage and cell death were quantified.
    Findings: Intranasal administration of Bifidobacterium longum35624® or its isolated cell wall prior to virus inoculation significantly reduced viral load within the lungs and significantly improved survival. Reduced viral load was associated with reduced lung injury as suggested by cell death and vascular leakage markers, a shift from neutrophil to macrophage recruitment, reduced inflammatory cytokine levels (including IL-6), reduced type 1 and 2 interferon levels, but increased levels of interferon-λ and surfactant protein D. These protective effects were maintained when the bifidobacterial cell wall preparation was administered 24 h after viral inoculation. The protective effects were also observed for the Bifidobacterium longumPB-VIR™ strain.
    Interpretation: Exposure to these bifidobacterial strains protect against the inflammatory sequelae and damage associated with uncontrolled viral replication within the lung.
    Funding: This work has been funded, in part, by a research grant from GlaxoSmithKline, PrecisionBiotics Group Ltd., Swiss National Science Foundation grants (project numbers CRSII3_154488, 310030_144219, 310030_127356 and 310030_144219) and Christine Kühne - Center for Allergy Research and Education (CK-CARE).
    MeSH term(s) Administration, Intranasal ; Animals ; Bifidobacterium longum/immunology ; Coinfection/immunology ; Coinfection/microbiology ; Coinfection/virology ; Cross Protection/immunology ; Cytokines/metabolism ; Disease Models, Animal ; Female ; Host-Pathogen Interactions/immunology ; Inflammation Mediators/metabolism ; Influenza A virus/immunology ; Mice ; Mortality ; Nasal Cavity/immunology ; Nasal Cavity/microbiology ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/metabolism ; Orthomyxoviridae Infections/mortality ; Orthomyxoviridae Infections/pathology ; Pneumonia, Viral/immunology ; Pneumonia, Viral/metabolism ; Pneumonia, Viral/mortality ; Pneumonia, Viral/pathology ; Prognosis
    Chemical Substances Cytokines ; Inflammation Mediators
    Keywords covid19
    Language English
    Publishing date 2020-09-11
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2851331-9
    ISSN 2352-3964
    ISSN (online) 2352-3964
    DOI 10.1016/j.ebiom.2020.102981
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection

    David Groeger / Elisa Schiavi / Ray Grant / Magdalena Kurnik-Łucka / David Michalovich / Rick Williamson / Soren Beinke / Barry Kiely / Cezmi A Akdis / Edith M Hessel / Fergus Shanahan / Liam O’ Mahony

    EBioMedicine, Vol 60, Iss , Pp 102981- (2020)

    2020  

    Abstract: Background: Prophylactic strategies are urgently needed for prevention of severe inflammatory responses to respiratory viral infections. Bacterial-host interactions may modify the immune response to viral infections. Methods: We examined the contribution ...

    Abstract Background: Prophylactic strategies are urgently needed for prevention of severe inflammatory responses to respiratory viral infections. Bacterial-host interactions may modify the immune response to viral infections. Methods: We examined the contribution of Intranasal administration of two different Bifidobacterium longum strains or its isolated cell wall in controlling viral induced inflammation using a murine model of influenza infection. We monitored mortality and morbidity over a 10-day period and viral load, differential broncho alveolar lavage (BAL) fluid inflammatory cell counts, Lung tissue histology, BAL and serum cytokines, markers of vascular damage and cell death were quantified. Findings: Intranasal administration of Bifidobacterium longum 35624® or its isolated cell wall prior to virus inoculation significantly reduced viral load within the lungs and significantly improved survival. Reduced viral load was associated with reduced lung injury as suggested by cell death and vascular leakage markers, a shift from neutrophil to macrophage recruitment, reduced inflammatory cytokine levels (including IL-6), reduced type 1 and 2 interferon levels, but increased levels of interferon-λ and surfactant protein D. These protective effects were maintained when the bifidobacterial cell wall preparation was administered 24 h after viral inoculation. The protective effects were also observed for the Bifidobacterium longum PB-VIR™ strain. Interpretation: Exposure to these bifidobacterial strains protect against the inflammatory sequelae and damage associated with uncontrolled viral replication within the lung. Funding: This work has been funded, in part, by a research grant from GlaxoSmithKline, PrecisionBiotics Group Ltd., Swiss National Science Foundation grants (project numbers CRSII3_154488, 310030_144219, 310030_127356 and 310030_144219) and Christine Kühne – Center for Allergy Research and Education (CK-CARE).
    Keywords Influenza ; Probiotic ; Interferon ; Prevention ; Medicine ; R ; Medicine (General) ; R5-920
    Subject code 610
    Language English
    Publishing date 2020-10-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.

    Davidson, Sophia / McCabe, Teresa M / Crotta, Stefania / Gad, Hans Henrik / Hessel, Edith M / Beinke, Soren / Hartmann, Rune / Wack, Andreas

    EMBO molecular medicine

    2016  Volume 8, Issue 9, Page(s) 1099–1112

    Abstract: Influenza A virus (IAV)-induced severe disease is characterized by infected lung epithelia, robust inflammatory responses and acute lung injury. Since type I interferon (IFNαβ) and type III interferon (IFNλ) are potent antiviral cytokines with ... ...

    Abstract Influenza A virus (IAV)-induced severe disease is characterized by infected lung epithelia, robust inflammatory responses and acute lung injury. Since type I interferon (IFNαβ) and type III interferon (IFNλ) are potent antiviral cytokines with immunomodulatory potential, we assessed their efficacy as IAV treatments. IFNλ treatment of IAV-infected Mx1-positive mice lowered viral load and protected from disease. IFNα treatment also restricted IAV replication but exacerbated disease. IFNα treatment increased pulmonary proinflammatory cytokine secretion, innate cell recruitment and epithelial cell death, unlike IFNλ-treatment. IFNλ lacked the direct stimulatory activity of IFNα on immune cells. In epithelia, both IFNs induced antiviral genes but no inflammatory cytokines. Similarly, human airway epithelia responded to both IFNα and IFNλ by induction of antiviral genes but not of cytokines, while hPBMCs responded only to IFNα. The restriction of both IFNλ responsiveness and productive IAV replication to pulmonary epithelia allows IFNλ to limit IAV spread through antiviral gene induction in relevant cells without overstimulating the immune system and driving immunopathology. We propose IFNλ as a non-inflammatory and hence superior treatment option for human IAV infection.
    MeSH term(s) Animals ; Cell Death ; Cytokines/analysis ; Disease Models, Animal ; Epithelial Cells/physiology ; Humans ; Influenza A virus/isolation & purification ; Interferon-alpha/therapeutic use ; Interleukins/therapeutic use ; Leukocytes/immunology ; Lung/pathology ; Mice ; Orthomyxoviridae Infections/drug therapy ; Orthomyxoviridae Infections/pathology ; Orthomyxoviridae Infections/prevention & control ; Orthomyxoviridae Infections/virology ; Treatment Outcome ; Viral Load
    Chemical Substances Cytokines ; IFNL4 protein, human ; Interferon-alpha ; Interleukins
    Keywords covid19
    Language English
    Publishing date 2016-09-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2467145-9
    ISSN 1757-4684 ; 1757-4676
    ISSN (online) 1757-4684
    ISSN 1757-4676
    DOI 10.15252/emmm.201606413
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: NF-KappaB1 p105 regulates Tpl-2 kinase

    Beinke, Sören

    Futura

    2003  Volume 18, Issue 3, Page(s) 183

    Language German
    Document type Article
    ZDB-ID 382906-6
    ISSN 0179-6372
    Database Current Contents Medicine

    More links

    Kategorien

  10. Article ; Online: IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment

    Sophia Davidson / Teresa M McCabe / Stefania Crotta / Hans Henrik Gad / Edith M Hessel / Soren Beinke / Rune Hartmann / Andreas Wack

    EMBO Molecular Medicine, Vol 8, Iss 9, Pp 1099-

    2016  Volume 1112

    Abstract: Abstract Influenza A virus (IAV)‐induced severe disease is characterized by infected lung epithelia, robust inflammatory responses and acute lung injury. Since type I interferon (IFNαβ) and type III interferon (IFNλ) are potent antiviral cytokines with ... ...

    Abstract Abstract Influenza A virus (IAV)‐induced severe disease is characterized by infected lung epithelia, robust inflammatory responses and acute lung injury. Since type I interferon (IFNαβ) and type III interferon (IFNλ) are potent antiviral cytokines with immunomodulatory potential, we assessed their efficacy as IAV treatments. IFNλ treatment of IAV‐infected Mx1‐positive mice lowered viral load and protected from disease. IFNα treatment also restricted IAV replication but exacerbated disease. IFNα treatment increased pulmonary proinflammatory cytokine secretion, innate cell recruitment and epithelial cell death, unlike IFNλ‐treatment. IFNλ lacked the direct stimulatory activity of IFNα on immune cells. In epithelia, both IFNs induced antiviral genes but no inflammatory cytokines. Similarly, human airway epithelia responded to both IFNα and IFNλ by induction of antiviral genes but not of cytokines, while hPBMCs responded only to IFNα. The restriction of both IFNλ responsiveness and productive IAV replication to pulmonary epithelia allows IFNλ to limit IAV spread through antiviral gene induction in relevant cells without overstimulating the immune system and driving immunopathology. We propose IFNλ as a non‐inflammatory and hence superior treatment option for human IAV infection.
    Keywords immunopathology ; infection ; influenza ; interferon alpha ; interferon lambda ; Medicine (General) ; R5-920 ; Genetics ; QH426-470
    Subject code 610 ; 570
    Language English
    Publishing date 2016-09-01T00:00:00Z
    Publisher Wiley
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top